Akumentis Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.29 M
- Paid Up Capital ₹ 1.15 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.00 Cr
- Satisfied Charges ₹ 27.50 Cr
- Revenue Growth 4.60%
- Profit Growth 62.07%
- Ebitda 37.83%
- Net Worth 77.26%
- Total Assets 36.88%
About Akumentis Healthcare
Akumentis Healthcare Limited (AHL) is a leading Public Limited Indian Non-Government Company incorporated in India on 29 July 2010 and has a history of 14 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.29 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹27.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Akumentis Healthcare Limited India is Ajay Dhiman as CEO. Mohammad Alam, Neena Vivek, Kanishk Jain, and Four other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900DL2010PLC206414
- Company No.
206414
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2010
- Date of AGM
29 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Akumentis Healthcare Limited offer?
Akumentis Healthcare Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Anti Infective Drugs & Medicines, Antiviral Drugs, Pharmaceutical Capsules, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Injectable Products.
Who are the key members and board of directors at Akumentis Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Dhiman | CEO | 04-Sep-2024 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neena Vivek  | Director | 19-Mar-2022 | Current |
| Mohammad Alam | Director | 29-May-2024 | Current |
| Kanishk Jain | Director | 29-Jun-2020 | Current |
| Sanjay Chalke | Whole-Time Director | 04-Sep-2020 | Current |
| Allen Dass | Director | 03-Jan-2013 | Current |
| Nand Kalra | Additional Director | 20-Aug-2024 | Current |
Financial Performance of Akumentis Healthcare.
Akumentis Healthcare Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.6% increase. The company also saw a substantial improvement in profitability, with a 62.07% increase in profit. The company's net worth Soared by an impressive increase of 77.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akumentis Healthcare?
In 2024, Akumentis Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shahbaz Pharma Private LimitedMohammad Alam is a mutual person
Delcure Lifesciences LimitedKanishk Jain is a mutual person
Pure And Cure Healthcare Private LimitedNand Kalra is a mutual person
- Akums Drugs And Pharmaceuticals Limited
Nand Kalra is a mutual person
- Malik Lifesciences Private Limited
Manmohan Singh is a mutual person
Unosource Pharma LimitedSanjay Chalke and Manmohan Singh are mutual person
Charges (Loans)
₹250.00 M
₹275.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 15.00 Cr
- Yes Bank Limited : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Oct 2016 | Yes Bank Limited | ₹10.00 Cr | Open |
| 02 Jan 2016 | Hdfc Bank Limited | ₹15.00 Cr | Open |
| 18 Mar 2011 | Icici Bank Limited | ₹27.50 Cr | Satisfied |
How Many Employees Work at Akumentis Healthcare?
Akumentis Healthcare has a workforce of 1459 employees as of Dec 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akumentis Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akumentis Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
